Skip to main content
PP114 Topic: AS13–Hematology/Oncology/Stem Cell Transplant/Immunology: MORTALITY IN CHILDREN WITH HEMOPHAGOCYTIC LYMPHOHISTIOCTYOSIS IN LOW-, LOW-MIDDLE-AND UPPER MIDDLE-INCOME COUNTRIES: A SYSTEMATIC REVIEW AND META-ANALYSIS.
PP334 Topic: AS09–Global Health/Resource Limited Setting/Health Inequalities/Impact of Global Warming/Other: COUNTRY SOCIODEMOGRAPHIC LEVEL AND PEDIATRIC CAUSE-SPECIFIC HOSPITAL CASE FATALITY RATES IN LOW- AND MIDDLE-INCOME COUNTRIES: A SYSTEMATIC REVIE
PP081 Topic: AS09–Global Health/Resource Limited Setting/Health Inequalities/Impact of Global Warming/Other: A SCOPING REVIEW TO IDENTIFY EXISTING CLASSIFICATION SYSTEMS FOR PEDIATRIC CRITICAL ILLNESS.
PP071 Topic: AS09–Global Health/Resource Limited Setting/Health Inequalities/Impact of Global Warming/Other: EXPLORING THE PROBLEM OF SUBSTANDARD AND FALSIFIED DRUGS IN HOSPITAL SETTINGS WORLDWIDE.
PP069 Topic: AS09–Global Health/Resource Limited Setting/Health Inequalities/Impact of Global Warming/Other: DEVELOPMENT OF A NOVEL PEDIATRIC CRITICAL CARE RESOURCE EVALUATION (CRITCARE) TOOL FOR HOSPITALS IN RESOURCE VARIABLE SETTINGS.
OP013 Topic: AS09–Global Health/Resource Limited Setting/Health Inequalities/Impact of Global Warming/Other: ESTIMATE OF PEDIATRIC ACUTE CRITICAL ILLNESS ACROSS RESOURCE-LIMITED SETTINGS: THE GLOBAL PAEDIATRIC ACUTE CRITICAL ILLNESS POINT PREVALENCE STU
PP101 [Global health » Resource limited settings]: DEFINING PEDIATRIC CRITICAL ILLNESS FOR RESEARCH ACROSS RESOURCE VARIABLE SETTINGS: A MODIFIED DELPHI CONSENSUS.
PP115 [Global health » Resource limited settings]: GLOBAL PARITY: A GLOBAL POINT PREVALENCE STUDY OF PEDIATRIC ACUTE CRITICAL ILLNESS IN RESOURCE-LIMITED SETTINGS.
PP108 [Global health » Resource limited settings]: CHALLENGES IN INSTITUTIONAL ETHICS REVIEW AND APPROVAL PROCESS FOR A MULTI-NATIONAL, MULTI-CENTER STUDY IN RESOURCE-LIMITED SETTINGS: THE GLOBAL PARITY STUDY.
P0379 / #660: AN EXPLORATORY EVALUATION OF THE SEVERITY OF ALVEOLAR EPITHELIAL INJURY IN OBESE AND NON-OBESE PEDIATRIC ACUTE RESPIRATORY FAILURE PATIENTS.